Literature DB >> 12821449

Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae.

Luz Balsalobre1, María José Ferrándiz, Josefina Liñares, Fe Tubau, Adela G de la Campa.   

Abstract

A total of 46 ciprofloxacin-resistant (Cip(r)) Streptococcus pneumoniae strains were isolated from 1991 to 2001 at the Hospital of Bellvitge. Five of these strains showed unexpectedly high rates of nucleotide variations in the quinolone resistance-determining regions (QRDRs) of their parC, parE, and gyrA genes. The nucleotide sequence of the full-length parC, parE, and gyrA genes of one of these isolates revealed a mosaic structure compatible with an interspecific recombination origin. Southern blot analysis and nucleotide sequence determinations showed the presence of an ant-like gene in the intergenic parE-parC regions of the S. pneumoniae Cip(r) isolates with high rates of variations in their parE and parC QRDRs. The ant-like gene was absent from typical S. pneumoniae strains, whereas it was present in the intergenic parE-parC regions of the viridans group streptococci (Streptococcus mitis and Streptococcus oralis). These results suggest that the viridans group streptococci are acting as donors in the horizontal transfer of fluoroquinolone resistance genes to S. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12821449      PMCID: PMC161831          DOI: 10.1128/AAC.47.7.2072-2081.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  52 in total

1.  Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.

Authors:  Ross Davidson; Rodrigo Cavalcanti; James L Brunton; Darrin J Bast; Joyce C S de Azavedo; Pamela Kibsey; Christine Fleming; Donald E Low
Journal:  N Engl J Med       Date:  2002-03-07       Impact factor: 91.245

2.  Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae.

Authors:  C G Dowson; A Hutchison; J A Brannigan; R C George; D Hansman; J Liñares; A Tomasz; J M Smith; B G Spratt
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 3.  Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996).

Authors:  A Fenoll; I Jado; D Vicioso; A Pérez; J Casal
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

4.  Antimicrobial susceptibilities of Streptococcus species that cause septicemia in neutropenic patients.

Authors:  M Venditti; P Baiocchi; C Santini; C Brandimarte; P Serra; G Gentile; C Girmenia; P Martino
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

5.  Production of pneumolysin, a pneumococcal toxin, in Bacillus subtilis.

Authors:  S Taira; E Jalonen; J C Paton; M Sarvas; K Runeberg-Nyman
Journal:  Gene       Date:  1989-04-30       Impact factor: 3.688

6.  Mefloquine and new related compounds target the F(0) complex of the F(0)F(1) H(+)-ATPase of Streptococcus pneumoniae.

Authors:  Antonio Javier Martín-Galiano; Begoña Gorgojo; Calvin M Kunin; Adela G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

7.  DNA probe for identification of Streptococcus pneumoniae.

Authors:  G Pozzi; M R Oggioni; A Tomasz
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

8.  Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain.

Authors:  E Pérez-Trallero; C Fernández-Mazarrasa; C García-Rey; E Bouza; L Aguilar; J García-de-Lomas; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

9.  Fluoroquinolone-resistant Streptococcus pneumoniae strains occur frequently in elderly patients in Japan.

Authors:  Shin-Ichi Yokota; Kiyoshi Sato; Osamu Kuwahara; Satoshi Habadera; Naoyuki Tsukamoto; Hironori Ohuchi; Hirotsugu Akizawa; Tetsuo Himi; Nobuhiro Fujii
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

10.  Viridans streptococcal endocarditis: the role of various species, including pyridoxal-dependent streptococci.

Authors:  R B Roberts; A G Krieger; N L Schiller; K C Gross
Journal:  Rev Infect Dis       Date:  1979 Nov-Dec
View more
  46 in total

1.  New species genetic approach to identify strains of mitis group streptococci that are donors of rifampin resistance to Streptococcus pneumoniae.

Authors:  María-José Ferrándiz; Carmen Ardanuy; Josefina Liñares; Luz Balsalobre; María Teresa García; Adela G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

2.  Molecular characterization of disease-associated streptococci of the mitis group that are optochin susceptible.

Authors:  Luz Balsalobre; Antonia Hernández-Madrid; Daniel Llull; Antonio J Martín-Galiano; Ernesto García; Asunción Fenoll; Adela G de la Campa
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

3.  Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US Study.

Authors:  Steven D Brown; David J Farrell; Ian Morrissey
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

4.  Clinical Isolates of the Spain14-5 clone of Streptococcus pneumoniae carry a recombinant rpoB gene.

Authors:  M J Ferrándiz; E Pérez-Trallero; J M Marimón; A G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

5.  Interspecies recombination in type II topoisomerase genes is not a major cause of fluoroquinolone resistance in invasive Streptococcus pneumoniae isolates in the United States.

Authors:  Mathias W R Pletz; Lesley McGee; Bernard Beall; Cynthia G Whitney; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 6.  The TetR family of transcriptional repressors.

Authors:  Juan L Ramos; Manuel Martínez-Bueno; Antonio J Molina-Henares; Wilson Terán; Kazuya Watanabe; Xiaodong Zhang; María Trinidad Gallegos; Richard Brennan; Raquel Tobes
Journal:  Microbiol Mol Biol Rev       Date:  2005-06       Impact factor: 11.056

7.  First characterization of fluoroquinolone resistance in Streptococcus suis.

Authors:  Jose Antonio Escudero; Alvaro San Millan; Ana Catalan; Adela G de la Campa; Estefania Rivero; Gema Lopez; Lucas Dominguez; Miguel Angel Moreno; Bruno Gonzalez-Zorn
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

8.  Independent behavior of commensal flora for carriage of fluoroquinolone-resistant bacteria in patients at admission.

Authors:  Victoire de Lastours; Françoise Chau; Florence Tubach; Blandine Pasquet; Etienne Ruppé; Bruno Fantin
Journal:  Antimicrob Agents Chemother       Date:  2010-09-27       Impact factor: 5.191

9.  Characterization of LytA-like N-acetylmuramoyl-L-alanine amidases from two new Streptococcus mitis bacteriophages provides insights into the properties of the major pneumococcal autolysin.

Authors:  Patricia Romero; Rubens López; Ernesto García
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

10.  Identification of a secreted cholesterol-dependent cytolysin (mitilysin) from Streptococcus mitis.

Authors:  Johanna Jefferies; Leena Nieminen; Lea-Ann Kirkham; Calum Johnston; Andrew Smith; Tim J Mitchell
Journal:  J Bacteriol       Date:  2006-10-27       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.